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Directly Observed Treatment, Short-course).10 The
DOTS strategy consists of a five point policy package:
political commitment, sputum smear microscopy for
diagnosis of infectious patients, standardised short
course (that is, rifampicin based) chemotherapy, secure
drug supply, and a recording and reporting system.
The DOTS strategy represents the basic minimum
necessary for control of tuberculosis. Implementing
the strategy requires flexibility, with adaptation to a
broad range of contexts and community needs.11
WHO recommends “standardised short-course
chemotherapy . . . under proper case management
conditions,” with the aim of adherence, completion of
treatment, and therefore tuberculosis cure and preven-
tion of drug resistance. These refer to a range of meas-
ures, including DOT, aimed at promoting treatment
adherence and completion. These include placing the
patient at the centre of activities for the control of
tuberculosis, ensuring confidentiality and considera-
tion of patients’ needs, organising tuberculosis services
so that the patient has treatment as close to home as
possible, considering incentives, identifying potential
problems, keeping accurate address records, and
taking measures to deal with defaulters.
The long experience of promoting adherence to
treatment of tuberculosis can inform the development
of the concept of concordance. An agreement between
a patient with tuberculosis and the healthcare provider
reinforces their mutual contribution and responsibility
to achieve successful treatment. Concordance is there-
fore a key step at the start of the dynamic process of
supporting a patient with tuberculosis throughout
treatment. The Bangladesh Rural Advancement Com-
mittee approach provides a good example of concord-
ance. After signing a written agreement, the patient is
supported by a community health worker throughout
the full course of treatment, and the programme
achieves a high cure rate (at least 85%).12
An enhanced concept of concordance embraces
the initial agreement between patient and healthcare
provider, and also measures for ongoing support for
patients to enable them to complete treatment. This is
relevant to successful outcomes of treatment of
communicable and non-communicable disease.
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Directly observed treatment for tuberculosis
Less faith, more science would be helpful
Drugs cure tuberculosis. So why does the diseaseremain in the top 10 causes of globalmortality, with 1.8 million deaths a year?1 Most
deaths are in low and middle income countries, where
a major challenge is to ensure that drugs are available
and people complete the long treatment. The World
Health Organization has been tackling the global
problem of inadequate tuberculosis control for some
years and launched a new programme of integrated
care in 1994, called directly observed treatment, short
course (DOTS).2 By using a six month course of drugs,
including rifampicin, WHO has mobilised money,
people, and systems in countries to tackle the global
problem with good progress.3 Its strategy is divided
into five key aspects: political commitment, access to
sputum microscopy, short course chemotherapy using
direct observation of treatment, an uninterrupted sup-
ply of drugs, and a recording and reporting system.
There is little argument that resources, drugs,
political support, and active management of pro-
grammes help improve control of tuberculosis.
However, debate continues over whether direct obser-
vation of patients taking their treatment by health
workers (or their delegates) is essential for successful
control. It seems to have arisen out of special
programmes in the United States, where direct
observation of treatment was part of multifaceted
strategies and special studies in Africa.4 It was at the
core of WHO’s strategy at launch in 1995, with the
director general saying that direct observation by a
health worker was the biggest health breakthrough this
decade. Direct observation remains core to the current
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WHO strategy: recently published guidelines say that
the key treatment principle of direct observation of
treatment remains the same, whichever method of
implementation is chosen.5 The problemwith this global
policy is that there are currently four carefully
conducted trials in Thailand, South Africa, and Pakistan,
and these studies show little or no advantage of direct
observation over self treatment at home in relation to
cure (figure).6 What is more, these studies were carried
out in settings with relatively low cure rates—exactly
where better control of tuberculosis is needed.
What are the implications for global policy with
these research results? We think that WHO and others
should reflect on the mismatch between this research
evidence and its own beliefs, expressed individually or
as consensus statements.5 7 8 Other data are of course
important, and this reflection needs also to consider
that direct observation costs more than other
methods,9 is paternalistic towards patients, and it can
take health workers away from other essential tasks.
Some health services may be of such poor quality that
patients would prefer not to attend, so potentially
direct observation could reduce adherence.
Enthusiasts make the world go round, but there is a
belief among specialists in tuberculosis that it is unethi-
cal not to provide direct observation. This attitude stifles
debate and good research into alternatives to direct
observation is replaced by semantics. For example, spe-
cialists state that “direct observation of treatment is
more than a mechanical procedure of dropping medi-
cine into a patient’s mouth; it is a human bond between
a patient and the health worker, to transmit a
recognition of the value of treatment success.”7 What
would be more helpful is to look at all the strategies to
promote adherence. For example, we know that
defaulter retrieval action seems to work in some
settings;10 so why not try defaulter actions for self treat-
ing patients who do not visit the clinic once a month?
What about some good research on staff support and
supervision, health education, or various forms of
prepackaging? What about peer assisted treatment sup-
port? We need a variety of methods to help patients
complete their treatment, as well as exploring the
circumstances where direct observation will be useful.
The energy going into insisting that direct observa-
tion is essential and non-negotiable has its own
opportunity costs. We believe that there are good
arguments for dropping the insistence on direct
observation and turning the passion into credible
methods for developing, evaluating, and promoting sus-
tainable measures to improve adherence.
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The patient’s perspective on medicines in
mental illness
Drug treatment is only a part of what the patient needs
Worldwide 40 antipsychotic preparations areavailable and twice as many antidepres-sants. As a patient with a recurrent depres-
sive disorder myself it would be comforting to think
that choice of treatment is based on a concordance
between the patient’s wishes and the doctor’s advice. In
reality it will reflect the many factors that affect their
relationship—medical attitudes; the way information is
presented; the capacity of patients to understand this
information and to relate it to their condition; health
service, social, and commercial pressures. Not surpris-
ingly, Cochrane reviews of interventions to improve
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